2018
DOI: 10.1016/j.jviromet.2018.07.006
|View full text |Cite
|
Sign up to set email alerts
|

Sanger-based sequencing technology for yellow fever vaccine genetic quality control

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
12
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(14 citation statements)
references
References 17 publications
2
12
0
Order By: Relevance
“…The technically uncovered regions of the 211 selected genes in the amplicon‐based next‐generation sequencing analysis were sequenced directly by Sanger sequencing. Only bases with quality values above 20 (<1% probability of the base being incorrect) were considered for further data analysis 39 …”
Section: Methodsmentioning
confidence: 99%
“…The technically uncovered regions of the 211 selected genes in the amplicon‐based next‐generation sequencing analysis were sequenced directly by Sanger sequencing. Only bases with quality values above 20 (<1% probability of the base being incorrect) were considered for further data analysis 39 …”
Section: Methodsmentioning
confidence: 99%
“…The severe viscerotropic disease caused by YFV has a high mortality rate, ranging from 25% to 50% 13 - 15 . The yellow fever virus is one of the most critical arboviruses.…”
Section: Introductionmentioning
confidence: 99%
“…In more severe cases, internal hemorrhage, kidney failure, shock, coma or even death can occur 11 . In the most severe cases, the mortality rate is between 20-50% 15 . Genetic factors seem to offer some protection, but according to Monath and Vasconcelos 11 , more studies are required to prove this hypothesis.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations